Evaluating cognitive disturbances as treatment target and predictor of antidepressant action in major depressive disorder: A NeuroPharm study

Cognitive disturbances in major depressive disorder (MDD) constitute a critical treatment target and hold promise as an early predictor of antidepressant treatment response; yet their clinical relevance is not fully established. Therefore, we here investigate if (1) cognitive performance improves ov...

Descripción completa

Detalles Bibliográficos
Autores principales: Dam, Vibeke Høyrup, Stenbæk, Dea Siggaard, Köhler-Forsberg, Kristin, Cheng Ip, Ozenne, Brice, Sahakian, Barbara Jacquelyn, Knudsen, Gitte Moos, Jørgensen, Martin Balslev, Frokjaer, Vibe Gedsoe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9643376/
https://www.ncbi.nlm.nih.gov/pubmed/36347845
http://dx.doi.org/10.1038/s41398-022-02240-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9643376/
https://www.ncbi.nlm.nih.gov/pubmed/36347845
http://dx.doi.org/10.1038/s41398-022-02240-1

Ejemplares similares